Société Ventrus Biosciences Inc Nasdaq
Actions
US9228221019
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- USD | - |
Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 0 | nan % | 7 | 100,0 % | - |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 7 | 100,0 % | - |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 48 | 30/03/20 |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | 46 | 08/11 |
William Delaney
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/06/20 |
John McHutchison
BRD | Director/Board Member | 66 | 06/08/19 |
Shannon Ryan
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | 01/08/19 | |
General Counsel | - | 01/09/22 | |
Nicole White
PRN | Corporate Officer/Principal | 44 | 17/11/20 |
Human Resources Officer | - | 01/05/17 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 59 | 14/12/17 |
Gina Consylman
BRD | Director/Board Member | 52 | 20/10/20 |
William Ringo
CHM | Chairman | 78 | 01/07/14 |
Anthony Altig
BRD | Director/Board Member | 68 | 01/01/12 |
Jason Okazaki
CEO | Chief Executive Officer | 48 | 30/03/20 |
Michael Houghton
BRD | Director/Board Member | 73 | 19/07/21 |
John McHutchison
BRD | Director/Board Member | 66 | 06/08/19 |
Tomas Cihlar
BRD | Director/Board Member | 57 | 07/12 |
Director/Board Member | 60 | 20/05/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 5 513 308 | 3 690 474 ( 66,94 %) | 0 | 66,94 % |
Coordonnées société
Assembly Biosciences, Inc.
Two Tower Place 7th floor
94080, South San Francisco
+833 509 4583
http://www.assemblybio.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+7,22% | 72,5 Md | |
+14,09% | 9,11 Md | |
-11,75% | 5,07 Md | |
+59,61% | 5,01 Md | |
+2,62% | 3,85 Md | |
-17,54% | 2,46 Md | |
+21,35% | 2,44 Md | |
-27,82% | 2,26 Md | |
+25,13% | 2,27 Md |
- Bourse
- Actions
- Action ASMB
- Action
- Société Ventrus Biosciences Inc